Axcan Pharma Inc

Summary

Introduction

Axcan Pharma is a leading specialty pharmaceutical company that develops and markets a range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency.

Scope

• Contains corporate strategy, value chain presence and SWOT Analysis
• Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
• Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Axcan's strategy is to grow its business by increasing market penetration and sales of existing products, developing and obtaining marketing approval for new products, in-licensing products and acquiring new products or companies, development of its research and development portfolio, and expanding geographically.

Currently, the company markets more than 40 products and dosage strengths worldwide in the field of gastroenterology. Axcan's major products include Ultrase (Pancreatic Diseases), Urso (Cirrhosis), Canasa (Proctitis) and Carafate (Duodenal Ulcer).

Axcan's all of the revenue has historically been and continues to be principally derived from sales of pharmaceutical products. The company's total revenues increased at a CAGR of 22% during 2002-2006, from $132 million to $292 million.

Reasons to Purchase

• Access all the important information and analysis on the company in a single report
• Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Contents

• Overview
• Catalyst
• Summary
• Company Structure
  • Company Overview And Key Facts
  • Business Description
  • History
  • Locations And Subsidiaries
  • Company Financials
  • Stock Market Performance
  • P&L
  • Balance Sheet
  • Cash Flow
  • Geographic Segment Performance
  • Products & Services
  • Marketed Products
  • Pipeline Products
  • Ac Forecast Product Sales
  • Competitors And Strategic Business Relationships
  • Key Competitors
  • Key Suppliers
  • Key Clients
  • Shareholding Structure
  • Strategy
  • Company View
  • Corporate Strategy
  • Swot Analysis
  • Overview
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
  • Value Chain Analysis
  • Overview
  • Product Development
  • Sales
  • Scorecard
  • Overview
  • Scorecard Analysis
  • Key Employees
  • List Of Key Employees
  • Key Employee Biographies
  • Financial And Operational Overview
  • Financial And Operational Overview
• Appendix
• Ask The Analyst
• Datamonitor Consulting
• Disclaimer
• Table Of Figures
  • Figure 1: Axcan Pharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
• Table Of Tables
  • Table 1: Axcan Pharma - Key Facts
  • Table 2: Axcan Pharma - Locations And Subsidiaries
  • Table 3: Axcan Pharma - Year-End Share Price And Market Capitalization, 2002-2006 ($)
  • Table 4: Axcan Pharma - Key Events Impacting Share Price Performance
  • Table 5: Axcan Pharma - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
  • Table 6: Axcan Pharma - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
  • Table 7: Axcan Pharma - Balance Sheet, 2002-2006 ($ Mn)
  • Table 8: Axcan Pharma - Cash Flow, 2002-2006 ($ Mn)
  • Table 9: Axcan Pharma - Geographic Breakdown, 2002-2006 ($ Mn)
  • Table 10: Axcan Pharma - Marketed Products
  • Table 11: Axcan Pharma - In-House Pipeline Products
  • Table 12: Axcan Pharma - Collaboration Products
  • Table 13: Axcan Pharma - Forecast Sales, 2006-2010 ($ Mn)
  • Table 14: Axcan Pharma - Key Competitors
  • Table 15: Axcan Pharma - Key Suppliers
  • Table 16: Axcan Pharma - Key Shareholders
  • Table 17: Axcan Pharma - Swot Analysis Summary
  • Table 18: Axcan Pharma - Value Chain Analysis
  • Table 19: Axcan Pharma - Scorecard
  • Table 20: Axcan Pharma - Key Employees
  • Table 21: Axcan Pharma - Financial And Operational Overview